Oncology Drug Development in 2026: From Scientific Innovation to Global Execution, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how sponsors can evaluate when emerging science in oncology is ready for clinical development and global execution. The featured speakers will discuss emerging evidence, biomarkers, dose optimization, adaptive approaches and the role of AI and multimodal data in development decisions. Attendees will also explore how to translate complex oncology science into global trial strategies across patient populations, geographies and regulatory environments.

TORONTO, Sept. 16, 2026 /PRNewswire/ -- Oncology innovation is accelerating across therapeutic modalities, precision medicine, biomarkers and artificial intelligence. But as scientific possibilities expand, the growing challenge for sponsors is determining what is ready to move forward and how to make critical oncology drug development decisions with greater confidence.

Increasingly, that means evaluating not only scientific promise, but whether innovations can be scaled across geographies, complex patient populations and regulatory environments to support successful global clinical development programs. This webinar will examine how to assess which advances are development-ready and translate them into scalable global strategies.

Ahead of the 2026 European Society for Medical Oncology (ESMO) Congress, Syneos Health® surveyed the oncology community to understand where leaders see the greatest opportunities and challenges in oncology clinical development. Responses highlighted strong interest in emerging scientific advances while reinforcing the need for practical guidance on trial design, execution and development strategy.

That reflects a broader industry reality: breakthrough science is advancing rapidly, but sponsors must still determine which innovations are ready to scale and how to translate scientific promise into clinical development and commercial impact.

That tension will anchor this webinar.

Following a brief, data-led presentation, oncology experts will examine what separates promising oncology innovation from development-ready science, and what it takes to translate emerging breakthroughs into scalable clinical trial and drug development strategies.

The conversation will look beyond individual ESMO readouts to ask a more consequential question: Which advances are truly ready to move oncology drug development forward, and what should sponsors be doing now to accelerate their impact?

Register for this webinar to learn how oncology drug development strategies can help translate emerging science into scalable global clinical programs.

Join Catarina Ribeiro, MD, Senior Medical Director, Oncology, Syneos Health; Alberto Puccini, MD, Medical Oncologist, IRCCS Humanitas Research Hospital, Humanitas Cancer Center; Martin Forster, MD, Associate Professor of Medical Oncology, University College London and Consultant Medical Oncologist, University College Hospital; Paul Nathan, MBBS, PhD, FRCP, Consultant Medical Oncologist, Mount Vernon Cancer Centre; and Elena Élez, MD, PhD, Head of the Gastrointestinal Tract Tumours Group, Vall d'Hebron Institute of Oncology, for the webinar offered as two live broadcasts on Tuesday, October 6, 2026, at 10am BST (11am CEST / EU-Central) and at 12pm EDT (6pm CEST / EU-Central).

For more information, or to register for this event, visit Oncology Drug Development in 2026: From Scientific Innovation to Global Execution (Broadcast 1).

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com

For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks